From off-label prescribing towards a new FDA
Author:
- Alex TabarrokATAlex Tabarrok
- 31 January 2009
- journal article
- editorial
- Published by Elsevier in Medical Hypotheses
- Vol. 72 (1) , 11-13
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Drug Target Identification Using Side-Effect SimilarityScience, 2008
- Regulating Off-Label Drug Use — Rethinking the Role of the FDANew England Journal of Medicine, 2008
- Off-label Prescribing Among Office-Based PhysiciansArchives of internal medicine (1960), 2006
- The Major Role of Clinicians in the Discovery of Off‐Label Drug TherapiesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Off-Label Drug Use in Human Immunodeficiency Virus DiseaseJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- An Evaluation of Consumer Protection Legislation: The 1962 Drug AmendmentsJournal of Political Economy, 1973